triiodothyronine has been researched along with imatinib mesylate in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
de Groot, JW; Links, TP; Plukker, JT; van Der Graaf, WT; Zonnenberg, BA | 1 |
Braun, D; Hershman, JM; Kim, TD; Köhrle, J; le Coutre, P; Schweizer, U | 1 |
Hou, Z; Liu, T; Zhu, HL | 1 |
1 trial(s) available for triiodothyronine and imatinib mesylate
Article | Year |
---|---|
Imatinib induces hypothyroidism in patients receiving levothyroxine.
Topics: Adult; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Medullary; Drug Synergism; Female; Gastrointestinal Stromal Tumors; Humans; Hypothyroidism; Imatinib Mesylate; Male; Middle Aged; Piperazines; Pyrimidines; Thyroid Neoplasms; Thyroidectomy; Thyrotropin; Thyroxine; Triiodothyronine | 2005 |
3 other study(ies) available for triiodothyronine and imatinib mesylate
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Tyrosine kinase inhibitors noncompetitively inhibit MCT8-mediated iodothyronine transport.
Topics: Animals; Benzamides; Binding, Competitive; Biological Transport; Cells, Cultured; Clinical Trials as Topic; Dogs; Down-Regulation; Drug Evaluation, Preclinical; Humans; Imatinib Mesylate; Indoles; Iodine Radioisotopes; Monocarboxylic Acid Transporters; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Sunitinib; Symporters; Thyroxine; Transfection; Triiodothyronine | 2012 |
[Effects of imatinib mesylate on the levels of endocrine hormones].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Benzamides; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Piperazines; Pyrimidines; Thyrotropin; Triiodothyronine; Young Adult | 2013 |